This includes offering learning opportunities through practical experience and co-developing a curriculum that facilitates access to innovative medicines, thereby strengthening a robust and sustainable public health system.
AstraZeneca Thailand and the Faculty of Pharmaceutical Sciences at Chulalongkorn University announce a strategic collaboration formalised through the signing of a Memorandum of Understanding (MOU) to enhance the potential of students and company personnel through various cooperative programmes. These programmes focus on developing essential knowledge and skills, alongside facilitating access to innovative medicines. This partnership also aims to elevate public health collaboration by fostering the capabilities of medical personnel who play a crucial role in driving Thailand's public health system. The signing ceremony was held at the Pharmacy 80th Year Building, Faculty of Pharmaceutical Sciences, Chulalongkorn University, and was witnessed by executives from both organisations.
This collaboration includes the "Early Talent Future Career Development" programme, which supports pharmacy students in developing their potential through internships aligned with industry standards, offering real-life experience. It also features workshops and lectures delivered by AstraZeneca personnel, preparing students for their future careers, commencing in May 2025. Furthermore, AstraZeneca Thailand and Chulalongkorn University are co-developing a curriculum focused on market access management, a critical component in enhancing access to innovative medicines for Thai patients and fostering collaborations between public and private sectors. The course, aimed at elevating the skills of AstraZeneca employees, is set to begin in June 2025.
Mr. Roman Ramos, President of AstraZeneca Thailand and Frontier Markets, stated, "AstraZeneca is deeply honoured to have earned the trust of the Faculty of Pharmaceutical Sciences at Chulalongkorn University. This collaboration is part of our strategy to continuously develop personnel capabilities, thereby enhancing the quality of life for patients in Thailand. AstraZeneca is committed to providing knowledge to support pharmaceutical education and to strengthening the public health system, aiming to improve and enhance the quality of life for the Thai people."
Associate Professor Dr. Vorasit Wongsutthilert, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, expressed, "The collaboration with AstraZeneca Thailand reaffirms the faculty's dedication to promoting excellence among pharmacy graduates by equipping them with essential skills for today's dynamic world and translating research into applicable innovations. This partnership will effectively elevate the potential of students and the pharmaceutical industry to meet future challenges and opportunities."
This partnership highlights the commitment of both organisations to personnel development and knowledge expansion in the pharmaceutical industry. It also underscores the confidence in Thailand's ability to advance medical professionals and public health systems in the future by sharing knowledge to promote societal progress and sustainably improve quality of life.
Free classes! "Earthquake" Online Course from Chula to Raise Disaster Awareness and Safety
Chulalongkorn University's Dance Programs: Bridging Conservation, Tradition, Innovation, and Research
PwC Thailand and Chulalongkorn University sign MoU to promote ESG knowledge and support sustainable community development
Chula Partners with World Economic Forum to Launch 2025 Gender Gap Report: Thailand Leads in Education and Health
Smart Jelly for Smart Aging: Chula's High-Protein Pudding Takes Global Stage
"Creating New Supply through Cluster Tourism: Leveraging Mobility Data to Turn Secondary Cities into Destinations of Choice and Revitalize Thailand's Tourism Sector"
Chulalongkorn University Leads the Conversation on Ethical and Inclusive AI at "AI for Society 2025" Seminar